Doxorubicin - CAS 23214-92-8
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Doxorubicin
Catalog Number:
23214-92-8
Synonyms:
Adriamycin
CAS Number:
23214-92-8
Description:
Doxorubicin(Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.
Molecular Weight:
543.52
Molecular Formula:
C27H29NO11
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 23214-92-8 Doxorubicin

Related ADCs Cytotoxin Products


CAS 41451-87-0 Turkesterone

Turkesterone
(CAS: 41451-87-0)

Turkesterone is a phytoecdysteroid possessing an 11alpha-hydroxyl group, also is an analogue of the insect steroid hormone 20-hydroxyecdysone.

CAS 147794-23-8 Omega-conotoxin MVIIC

Omega-conotoxin MVIIC
(CAS: 147794-23-8)

ω-conotoxin MVIIC (omega conotoxin MVIIC) is a conotoxin that has been isolated from the venom of the cone Conus magus. ω-conotoxin MVIIC is a blocker of P/Q an...

CAS 9083-23-2 Erabutoxin B

Erabutoxin B
(CAS: 9083-23-2)

an antagonist of the nicotinic acetylcholine receptor at the neuromuscular junction. Erabutoxin B from Laticauda semifasciata (Sea Snake)

Sevedindione

Sevedindione presents an antiarrhythmic activity on arrhythmias caused by Aconitine.

CAS 75433-28-2 Laticauda semifasciata III

Laticauda semifasciata III
(CAS: 75433-28-2)

Polypetide, an antagonist of the nicotinic acetylcholine receptor at the neuromuscular junction with a weaker affinity to the receptor than Erabutoxins a and b.

CAS 153720-48-0 3-alpha-chloro-Imperialine

3-alpha-chloro-Imperialine
(CAS: 153720-48-0)

A highly active peripheral M2-cholinoblocker alkaloid. Cervane alkaloid derivative of Imperialine from the plant Petilium eduardi.

CAS 60697-89-4 LK-190

LK-190
(CAS: 60697-89-4)

A muscarinic receptors antagonist.

CAS 78454-17-8 7-Epi 10-Desacetyl Paclitaxel

7-Epi 10-Desacetyl Paclitaxel
(CAS: 78454-17-8)

7-Epi 10-Desacetyl Paclitaxel is a derivative of Paclitaxel, which is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.

CAS 67526-95-8 Thapsigargin

Thapsigargin
(CAS: 67526-95-8)

Potent, cell-permeable, IP3-independent intracellular calcium releaser. Blocks the transient increase in intracellular Ca2+ induced by angiostatin and endostati...

CAS 153720-49-1 3-beta-chloro-Imperialine

3-beta-chloro-Imperialine
(CAS: 153720-49-1)

Cervane alkaloid derivative of Imperialine from the plant Petilium eduardi. A potent medium-lasting selective M2 muscarinic receptor antagonist.

Polyprenols
(CAS: 308068-00-0)

Polyprenols are natural long-chain isoprenoid alcohols of the general formula H-(C5H8)n-OH where n is the number of isoprene units. Any prenol with more than 4 ...

CAS 303-33-3 Heliotrine

Heliotrine
(CAS: 303-33-3)

Extract from plants of the Heliotropum genus, an alkaloid used for obtaining models of hepatitis and cirrhosis of the liver.

Tazettine
(CAS: 507-79-9)

Indole alkaloid Amaryllidaceae Fam. Plants

CAS 3476-50-4 N-Deacetylcolchicine

N-Deacetylcolchicine
(CAS: 3476-50-4)

An antimitotic agent that disrupts microtubles by binding to tubulin and preventing its polymerization. Stimulates the intrinsic GTPase activity of tubulin.

M1-Nitrodienamine
(CAS: 113418-72-7)

Nitrodienamine, an inhibitor of Ca2+/Mg2+ ATPase.

CAS 224790-70-9 Cloflubicyne

Cloflubicyne
(CAS: 224790-70-9)

Cloflubicyne is a potent non-competitive GABA antagonist, convulsant, laboratory insecticide.

LTx-004

A scorpion alpha-insect toxin, which prolongs the evoked action potential by an inhibition of sodium current inactivation in insects and mammals.

PLA2 Apis mellifera
(CAS: 9001-84-7)

Active enzyme isolated from bee venom · One unit of enzyme hydrolyzes one µmol of Diheptanoyl Thio-PC per minute at 25°C.

CAS 321938-55-0 Lycaconitine Perchlorate

Lycaconitine Perchlorate
(CAS: 321938-55-0)

A nicotinic antagonist.

CAS 50-07-7 Mitomycin C

Mitomycin C
(CAS: 50-07-7)

Mitomycin C is a DNA crosslinking agent that inhibits DNA synthesis and induces apoptosis in a variety of cells.

Reference Reading


1. Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics
Hanene Ali-Boucetta, Khuloud T. Al-Jamal, Kostas Kostarelos*. Chem. Commun., 2008, 459–461
In this communication, we describe a previously unreported non-covalent multiwalled nanotube (MWNT)–doxorubicin supra-molecular complex that can be developed for cancer therapy. We have investigated the ability of doxorubicin to interact non-covalently with very thin, pristine MWNT 1 at various mass ratios and evaluated their capability to kill human breast cancer cells. Doxorubicin belongs to a clinically-used family of anthracyclines, therefore constitutes one of the best candidates to test non-covalent complexation with MWNTs. Moreover, doxorubicin 3 is a fluorescent molecule with a chromophore composed of three planar and aromatic hydroxyanthraquinonic rings that are used to monitor its supramolecular interaction with MWNTs. MWNTs were dispersed in water using the tri-block copolymer.
2. Synthesis, in vitro and in vivo anticancer activity of novel 1-(4-imino-1-substituted-1H-pyrazolo[3,4-d] pyrimidin-5(4H)-yl)urea derivatives
Chandra Bhushan Mishra, Raj Kumar Mongre, Shikha Kumari, Dong Kee Jeong* and Manisha Tiwari*. RSC Adv.,2016, 6, 24491–24500
To study apoptosis by flow cytometer, A549 cells were treated with CBS-1 (5 μM and 10 μM) and doxorubicin (10 μM) for 24 h. In result, CBS-1 at 10 μM concentration showed significant (p <0.05) apoptosis against A549 cells and it was found better than doxorubicin (10 μM) as shown in Fig. 6 and Table 3. Result points out that CBS-1 (10 μM) showed 50.98% apoptosis and while doxorubicin (10 mM) displayed 22.74% apoptosis in 24 h. Thus, Hoechst 33342 staining and flow cytometry studies evidently indicate that CBS-1 (10 mM) showed better apoptosis against A549 cells as compared to doxorubicin.
3. Multifunctional ATRP based pH responsive polymeric nanoparticles for improved doxorubicin chemotherapy in breast cancer by proton sponge effect/endo-lysosomal escape
Shantanu V. Lale, Arun Kumar, Farhat Naz, Alok C. Bharti and Veena Koul*. Polym. Chem.,2015, 6,2115–2132
Polymer nanoparticles (NPs) for doxorubicin delivery in breast cancer have been investigated by many researchers to overcome the cardiotoxicity, non-specificity and acquired resistance of cancer cells to current doxorubicin chemotherapy. Polymeric nanoparticles help to improve the bioavailability of doxorubicin by passive targeting of tumors via an enhanced permeation and retention (EPR) effect, by increasing the circulation half-life of doxorubicin and by overcoming acquired cancer cell resistance. These polymeric nanosystems suffer from few drawbacks, which lead to a decreased antitumor efficacy of doxorubicin. Doxorubicin hydrochloride is a water-soluble drug, which makes it difficult to physically load doxorubicin into nanoparticles in sufficient amounts.